Discussion about this post

User's avatar
Richard Sharpe's avatar

Wait:

"We had reports from Israel as an example of the effectiveness of the 2 doses of the BNT162b2 (Pfizer-BioNTech) shot to be 39% which was significantly less than the trial’s reported efficacy of 96%"

How are those two even comparable since the number reported by Pfizer was the Relative Risk Reduction when looking at one symptom as the end-point while presumably the Israel data is looking at PCR-faked cases or perhaps even hospitalizations or etc.

Why can't they publish the Absolute Risk Reduction numbers for once?

Barry O'Kenyan's avatar

Actually, there is PERVERSE correlation: higher vaxes, higher cases.

See https://twitter.com/stevin2021/

No posts

Ready for more?